Awards & Advancement

PatientsLikeMe names Marni Hall senior vice president

Monday, July 11, 2016

PatientsLikeMe has appointed Marni Hall, Ph.D., MPH, as its new senior vice president of Research and Policy. A distinguished research scientist and public policy expert, Hall will develop and direct the strategies and teams focused on expanding the role of real-world evidence in precision medicine, and in the research agendas of PatientsLikeMe and its customers.

[Read More]

David Meek appointed Ipsen’s chief executive officer

Monday, July 11, 2016

The board of directors of Ipsen appointed David Meek as chief executive officer, effective July 18, 2016. On this date, Marc de Garidel will assume the role of non-executive chairman and will continue to serve the board of directors through his deep industry expertise. In addition, Marc de Garidel will advise Mayroy, the Ipsen controlling holding company.

[Read More]

PureTech expands scientific advisory board team and advisory group

Friday, July 8, 2016

PureTech Health, a cross-disciplinary biotech company developing novel medicines at the interface of the gut, brain and immune system, has announced the appointment of Feng Zhang, Ph.D., to its scientific advisory board (SAB). The company has also appointed Jeff Stevens, as vice president of Growth Strategy & Operations and has expanded its team of senior advisors to include Meghan Fitzgerald, DrPH, executive vice president of Corporate Strategy, M&A and Health Policy at Cardinal Health; Atul Pande, M.D., former senior vice president and head of Neurosciences at GlaxoSmithKline; and Philip J. Larsen, M.D., Ph.D., global head of Diabetes Research & Development at Sanofi.

[Read More]

Revive Therapeutics names Craig Leon CEO and president

Thursday, July 7, 2016

Revive Therapeutics has announced the appointment of Craig Leon, Revive’s chairman of the board, as chief executive officer. Fabio Chianelli, Revive’s current chief executive officer, will continue as president. These changes will permit Leon to dedicate his efforts to executing the company’s capital markets and business development strategies, while permitting Chianelli to focus on directing the company’s corporate operations and research and development programs.

[Read More]

PureTech Health’s Daphne Zohar named EY Entrepreneur Of The Year 2016

Tuesday, June 28, 2016

Daphne Zohar, co-founder and chief executive officer of PureTech Health, a cross-disciplinary biotech company tackling fundamental healthcare needs in disruptive ways, was named the EY Entrepreneur Of The Year 2016 in the New England program. The awards program, which is celebrating its 30th year, recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities.

[Read More]

Envigo appoints Hardy president and CEO, Cass executive chairman

Monday, June 27, 2016

Envigo has announced that its board of directors has appointed Dr. Adrian Hardy as president and chief executive officer, effective July 1. He will join the company’s board of directors. Dr. Hardy joined Envigo in 2002 and has held various roles of increasing responsibility in sales, strategic marketing and operations, most recently serving as COO. 

[Read More]

Verastem changes its board of directors

Monday, June 20, 2016

Verastem focused on discovering and developing drugs to treat cancer, has announced several changes to the company’s board of directors. Michael Kauffman, M.D., Ph.D., who has served as a director since November 2012, will become lead director and Bruce J. Wendel will join the board as an independent director.

[Read More]